the spirit and history of rare disease day
play

The Spirit and History of Rare Disease Day Anja Helm, Senior - PowerPoint PPT Presentation

May 21, 2023 •117 likes •338 views

The Spirit and History of Rare Disease Day Anja Helm, Senior Manager of Relations with Patient Organisations, EURORDIS 30/09/2014 eurordis.org eurordis.org 2 The Spirit of Rare Disease Day EURORDIS / Council of National Alliances in 2008

  2. The Spirit and History of Rare Disease Day Anja Helm, Senior Manager of Relations with Patient Organisations, EURORDIS 30/09/2014 eurordis.org eurordis.org 2

  3. The Spirit of Rare Disease Day • EURORDIS / Council of National Alliances in 2008 • Patient-driven awareness campaign • In 2010, anyone can participate: politicians, public authorities, policy-makers, industry representatives, researchers, health professionals and anyone who has a genuine interest in rare diseases • The spirit of Rare Disease Day means that the logo and materials are not to be used for commercial purposes 30/09/2014 3 eurordis.org

  4. Patient-driven - Countries and regions 84 in 2014 72 in 2013 63 in 2012 55 in 2011 46 in 2010 30 in 2009 18 in 2008… 4 eurordis.org

  5. Communications tools Logo, Infopack, Poster in 2008 Added Facebook, Flickr, Twitter, YouTube in 2009 Friends of Rare Disease Day in 2010 New turquoise visual in 2011 eurordis.org

  6. Communications tools Official video in 2012 Official video and poster in 2013 New website, Ambassador in 2014 Webinars in 2015 eurordis.org

  7. Rare Disease Day’s Success is YOU! Questions? 30/09/2014 7 eurordis.org

  8. Rare Disease Day in Ireland Successes and Difficulties Avril Daly Vice President, EURORDIS Chair, Genetics & Rare Disorders Organisation Chief Executive, Fighting Blindness

  9. Discussion Points 1. How did we get started? 2. Communication materials 3. Events that worked 4. Media attention 5. Fundraising

  10. How did we get started? • Building awareness • Using international campaign materials - logo, slogan, poster • Part of an international movement…

  11. Successes and difficulties • Events that worked • Getting media interested Step 3 — EUROPEAN Step 2 — YEAR FOR • Getting politicians involved POLICY Step 1 — RARE DISEASES ADVOCATE ACTIONS

  12. Fundraising • Creating momentum and awareness • Dangers?

  15. Thank You QUESTIONS? Avril Daly, Ireland Chair, Genetics & Rare Disorders Organisation

  16. A tutorial on intellectual property, value and potential misuse. EURORDIS Webinar - The Spirit of Rare Disease Day, 30 September 2014, Presentation by Thomas Kanga-Tona, Client Executive, Healthcare, Burson-Marsteller

  17. Best practice of logo use for participating associations A. A consistent logo… • …Improves your initiative’s identity • …Improves the initiative’s coherence • …Improves the initiative’s visibility • …Makes the initiative memorable • …Has a wider reach 17

  18. Best practice of logo use for participating associations (2) B. Simple safeguards exist… • …Always refer to the materials on the Rare Disease Day website • …Improve the accessibility of the Rare Disease Day website’s download section • …Improve the accessibility of the Rare Disease Day website’s disclaimer • …Ask EURORDIS if you have doubts 18

  19. Preventing the misuse of the RDD logo by third parties A. Letting third parties misuse the RDD logo… • …Harms the initiative’s identity • …Harms the initiative’s credibility • …Harms your organisation’s reputation 19

  20. Preventing the misuse of the RDD logo by third parties (2) B. You could address misuse by… • …Agreeing with external partners on the use of the logo • …Improving the accessibility of the disclaimer on good use of the RDD logo • …Referring to EURORDIS when a misuse occurs 20

  21. Question time

  22. Thank you!! Contact details: Thomas Kanga-Tona, Client Executive, Healthcare, Burson-Marsteller Brussels thomas.kanga-tona@bm.com

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend

CME / CE Rare Disease Clinical Trials Module: Rare Pulmonology Clinical Trials Timothy Craig,

CME / CE Rare Disease Clinical Trials Module: Rare Pulmonology Clinical Trials Timothy Craig,

CME / CE Rare Disease Clinical Trials Module: Rare Pulmonology Clinical Trials Timothy Craig, DO Penn State Health Rare Hematologic Conditions Rare Pulmonology Conditions What is a rare disease? A rare disease is any disease affecting

405 views • 14 slides
From gene discovery to therapies for rare disease a research perspective A/Prof Carol Wicking

From gene discovery to therapies for rare disease a research perspective A/Prof Carol Wicking

From gene discovery to therapies for rare disease a research perspective A/Prof Carol Wicking Director, IMB Centre for Rare Disease Research, UQ Rare Disease Summit 2015 Melbourne 27-28 March Why rare disease? Why now? Why

262 views • 12 slides
RAREDISEASEDAY.ORG 1 Rare Disease Day 2020 13 th edition on Saturday 29 February 2020

RAREDISEASEDAY.ORG 1 Rare Disease Day 2020 13 th edition on Saturday 29 February 2020

RAREDISEASEDAY.ORG 1 Rare Disease Day 2020 13 th edition on Saturday 29 February 2020 A rare day for rare diseases in this leap year! Key campaign message: Rare is many. Rare is strong. Rare is proud! RAREDISEASEDAY.ORG 2

853 views • 15 slides
CME / CE Rare Disease Clinical Trials Focus on Rare Hematologic Clinical Trials Morie A Gertz

CME / CE Rare Disease Clinical Trials Focus on Rare Hematologic Clinical Trials Morie A Gertz

CME / CE Rare Disease Clinical Trials Focus on Rare Hematologic Clinical Trials Morie A Gertz MD: Mayo Clinic; Rochester, MN Rare Hematologic Conditions Rare Hematologic Conditions Definition A rare disease is any disease affected less

477 views • 15 slides
2018 S CIENTIFIC W ORKSHOP #10 Conceptualizing an FDA Rare Disease Center of Excellence

2018 S CIENTIFIC W ORKSHOP #10 Conceptualizing an FDA Rare Disease Center of Excellence

@EveryLifeOrg 2018 S CIENTIFIC W ORKSHOP #10 Conceptualizing an FDA Rare Disease Center of Excellence Presented by ANNUAL RARE DISEASE SCIENTIFIC WORKSHOP Improving the Clinical Development Process Thank you to todays sponsors! ANNUAL RARE

618 views • 24 slides
Challenges with Producing Reliable Evidence for Rare Disease Breakout Advisory Panel on Rare

Challenges with Producing Reliable Evidence for Rare Disease Breakout Advisory Panel on Rare

Challenges with Producing Reliable Evidence for Rare Disease Breakout Advisory Panel on Rare Disease Winter 2016 Breakout Webinars January 27, 2016 Welcome and Agenda Naomi Aronson, PhD Methodology Committee, PCORI Danielle Whicher, PhD, MHS

243 views • 22 slides
and daily life: The Balancing Act of the Rare Disease Community Avril Daly, EURORDIS

and daily life: The Balancing Act of the Rare Disease Community Avril Daly, EURORDIS

Juggling care and daily life: The Balancing Act of the Rare Disease Community Avril Daly, EURORDIS Vice-President 17 th October 2017 Launch event of the Parliamentary Advocates for Rare Diseases #ParliamentAdvocate4Rare Rare diseases A rare

833 views • 26 slides
Severe, Rare Disease Case Study: Strategy Changes with FDA SPA Sponsors Challenge

Severe, Rare Disease Case Study: Strategy Changes with FDA SPA Sponsors Challenge

Severe, Rare Disease Case Study: Strategy Changes with FDA SPA Sponsors Challenge Raptor Pharmaceu.cals first drug to enter Phase 3 is for a rare metabolic disease severely

181 views • 5 slides
Gene Therapies for Rare Diseases September 13, 2018 Rare Disease Scientific Workshop Everylife

Gene Therapies for Rare Diseases September 13, 2018 Rare Disease Scientific Workshop Everylife

Gene Therapies for Rare Diseases September 13, 2018 Rare Disease Scientific Workshop Everylife Foundation for Rare Diseases Washington, DC Wilson W. Bryan Office of Tissues and Advanced Therapies (OTAT) Center for Biologics Evaluation and

510 views • 20 slides
Rare Disease Issues State by State Newbo Ne born S Screen eening ng Julia J a Jenki kins

Rare Disease Issues State by State Newbo Ne born S Screen eening ng Julia J a Jenki kins

Rare Disease Issues State by State Newbo Ne born S Screen eening ng Julia J a Jenki kins Exec ecutive Di e Direc ector, Ever eryLife Foundation f for R Rare Di e Disea eases ses Supporting Rare Disease Patients Through State

573 views • 16 slides
www.R .RareAd areAdvo voca cates.or tes.org DC Office with workstation & meeting space

www.R .RareAd areAdvo voca cates.or tes.org DC Office with workstation & meeting space

Designed to be a clearinghouse & advocacy center for all Rare Disease Legislation Provides resources & tools for individuals & organizations All events & resources are free & open to the entire Rare Disease

285 views • 12 slides
Building a Natural History Study for Canavan Disease Kathleen Kirby Head of Development

Building a Natural History Study for Canavan Disease Kathleen Kirby Head of Development

Building a Natural History Study for Canavan Disease Kathleen Kirby Head of Development Operations 5 September 2019 Who What When Where Why Canavan Disease Ultra rare leukodystrophy 1000 patients globally, 1:100,000 births Autosomal

383 views • 12 slides
C URE T HE P ROCESS 2: Improving the Development Process for Rare Disease Treatments Emil D.

C URE T HE P ROCESS 2: Improving the Development Process for Rare Disease Treatments Emil D.

C URE T HE P ROCESS 2: Improving the Development Process for Rare Disease Treatments Emil D. Kakkis, M.D., Ph.D. President and Founder October 29, 2014 1 About the Foundation: Dedicated to Accelerating Biotechnology Innovation for Rare

619 views • 22 slides
Rare Disease Workshop 5: Post Marketing Confirmatory Studies in Rare Diseases Susan Boynton, VP,

Rare Disease Workshop 5: Post Marketing Confirmatory Studies in Rare Diseases Susan Boynton, VP,

Rare Disease Workshop 5: Post Marketing Confirmatory Studies in Rare Diseases Susan Boynton, VP, Global Regulatory Affairs, Shire Mary O'Donovan, Senior Director, Regulatory Affairs & Policy, Biomarin Accelerated Approval: Requirements

318 views • 8 slides
EUROPEAN REFERENCE NETWORKS Matt Bolz-Johnson, EURORDIS Rare Disease Ireland, Dublin, Ireland

EUROPEAN REFERENCE NETWORKS Matt Bolz-Johnson, EURORDIS Rare Disease Ireland, Dublin, Ireland

EUROPEAN REFERENCE NETWORKS Matt Bolz-Johnson, EURORDIS Rare Disease Ireland, Dublin, Ireland 23 October 2018 Challenges we face as a community Rare diseases and rare cancers can be chronic, progressive, degenerative, disabling and

711 views • 25 slides
Research Prioritization Breakout Advisory Panel on Rare Disease Winter 2016 Breakout Webinars

Research Prioritization Breakout Advisory Panel on Rare Disease Winter 2016 Breakout Webinars

Research Prioritization Breakout Advisory Panel on Rare Disease Winter 2016 Breakout Webinars January 27, 2016 Welcome and Agenda Marilyn Bull, MD, FAAP Member, Advisory Panel on Rare Disease, PCORI Parag Aggarwal, PhD Senior Program Officer,

354 views • 18 slides
An introduction to Patterns, Profiles, HMMs and PSI-BLAST Marco Pagni, Lorenzo Cerutti and

An introduction to Patterns, Profiles, HMMs and PSI-BLAST Marco Pagni, Lorenzo Cerutti and

Patterns, Profiles, HMMs, PSI-BLAST Cours e 200 4 An introduction to Patterns, Profiles, HMMs and PSI-BLAST Marco Pagni, Lorenzo Cerutti and Lorenza Bordoli Swiss Institute of Bioinformatics EMBnet Course, Zrich , October 200 4 Patterns,

489 views • 46 slides
Local perspective of mixing - a CSP approach Stathis Stathakidis Department of Computing

Local perspective of mixing - a CSP approach Stathis Stathakidis Department of Computing

Outline Mixnets Assumptions Algorithms CSP Problems and future work Questions Local perspective of mixing - a CSP approach Stathis Stathakidis Department of Computing University of Surrey, UK 15 October 2012 E. Stathakidis Local

725 views • 51 slides
Leptophilic Higgs Leptophilic Higgs Signatures at the LHC Signatures at the LHC (And the

Leptophilic Higgs Leptophilic Higgs Signatures at the LHC Signatures at the LHC (And the

Leptophilic Higgs Leptophilic Higgs Signatures at the LHC Signatures at the LHC (And the Importance of Leptonic Decays for Higgs Discovery) Brooks Thomas (The University of Arizona) Shufang Su & BT [arXiv:0903.0667] What do we know about

375 views • 26 slides
DIRECTIVE N O : D-P4 070101 2 Revision: 03 I NCIDENT R EPORTING R EQUIREMENTS WITH R ESPECT TO A

DIRECTIVE N O : D-P4 070101 2 Revision: 03 I NCIDENT R EPORTING R EQUIREMENTS WITH R ESPECT TO A

DIRECTIVE N O : D-P4 070101 2 Revision: 03 I NCIDENT R EPORTING R EQUIREMENTS WITH R ESPECT TO A MUSEMENT Devices (I NCLUDING W ATER S LIDES) This Directive supersedes Directive D-P4 040730 4 issued on July 30, 2004. This Directive is being issued

250 views • 3 slides
The Tor Project Our mission is to be the global resource for technology, advocacy, research and

The Tor Project Our mission is to be the global resource for technology, advocacy, research and

The Tor Project Our mission is to be the global resource for technology, advocacy, research and education in the ongoing pursuit of freedom of speech, privacy rights online, and censorship circumvention. 1 What is Tor? Online anonymity 1)

593 views • 35 slides
Chapter 12 Fundraising and Development Management & the Arts, 5e, (C) Wm. Byrnes, 2014

Chapter 12 Fundraising and Development Management & the Arts, 5e, (C) Wm. Byrnes, 2014

Chapter 12 Fundraising and Development Management & the Arts, 5e, (C) Wm. Byrnes, 2014 Chapter Overview The fundraising and development activities in an arts organization are central to its survival. The support of the marketing and public

657 views • 10 slides
Franklyn Street Glebe Redevelopment Proposal Welcome to the webinar NOVEMBER 2020

Franklyn Street Glebe Redevelopment Proposal Welcome to the webinar NOVEMBER 2020

Franklyn Street Glebe Redevelopment Proposal Welcome to the webinar NOVEMBER 2020 Acknowledgement of Country The NSW Government acknowledges and pays tribute to the unique cultural and spiritual relationship that Aboriginal communities have

642 views • 40 slides
SPRC #3 July 22, 2019 1. Removed second entrance to Building 2 parking near the park. 2.

SPRC #3 July 22, 2019 1. Removed second entrance to Building 2 parking near the park. 2.

TEAM Harris Teeter Southeastern Property Acquisitions LLC DCS Design Venable LLP VIKA Engineering Gorove/Slade Associates Parker Rodriguez CBG SPRC #3 July 22, 2019 1. Removed second entrance to Building 2 parking near the park. 2.

762 views • 52 slides

More recommend